Home
/
Treatment
/
(S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester

(S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester

	(S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester
Trade Name
Orphan Indication	Pulmonary Arterial Hypertension
EU Market Approval	EU
EU Designation Date	2017-04-20 00:00:00
Sponsor	Biological Consulting Europe Ltd

Related Access Program

Pfizer – Pulmonary Arterial Hypertension (PAH) Pfizer – Pulmonary Arterial Hypertension Bayer – Pulmonary arterial hypertension